6611 Tributary Street
Baltimore, MD 21224

Directions to our Headquarters

Guilford manufactures GLIADEL
® Wafer at its 83,000 square foot corporate headquarters in Baltimore in approximately 17,500 square feet of manufacturing, quality control, analytical chemistry, process development, packaging and warehousing space. Current manufacturing capacity is approximately 8,000 GLIADEL® Wafer treatments a year. The Company has completed construction of a second manufacturing facility which can also be used for the production of additional GLIADEL® Wafers and other polymer-based products.

6411 Beckley Street
Baltimore, MD 21224

Directions to our R&D Facility

On June 26, 1999, Guilford held a grand opening ceremony for its new 73,000 square foot Research and Development facility, located on a lot adjacent to its corporate offices. This new state-of-the-art research and development facility houses approximately 185 scientists and R&D support personnel.

This page was last updated on Monday, December 9, 2002

Copyright© 2002 Guilford Pharmaceuticals Inc.
Legal Information